Brief: Astrazeneca Pharma India Dec-Quarter PAT 308.5 Mln Rupees
11/02/2025 13:43
Feb 11 (Reuters) - Astrazeneca Pharma India Ltd
ASTR.NS :
* DEC-QUARTER PAT 308.5 MILLION RUPEES
* DEC-QUARTER REVENUE FROM OPERATIONS 4.4 BILLION RUPEES
Source text: ID:nBSE7glxPw
Further company coverage: ASTR.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma India Receives Permission To Import And Sell Trastuzumab Deruxtecan For Additional Indication
Brief: Astrazeneca Pharma Says Bhavana Agrawal Resigns As CFO
Brief: Astrazeneca Pharma India Receives Permission To Import And Sell Benralizumab For Additional Indication
Brief: Astrazeneca Pharma India Receives Permission To Import Benralizumab (Fasenra) For Additional Indication
Brief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan